SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-050250
Filing Date
2017-08-08
Accepted
2017-08-08 16:06:45
Documents
60
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-13377_110q.htm 10-Q 895540
2 EX-4.1 a17-13377_1ex4d1.htm EX-4.1 9134
3 EX-31.1 a17-13377_1ex31d1.htm EX-31.1 11899
4 EX-31.2 a17-13377_1ex31d2.htm EX-31.2 11882
5 EX-32.1 a17-13377_1ex32d1.htm EX-32.1 7477
12 GRAPHIC g133771kk03i001.gif GRAPHIC 80631
13 GRAPHIC g133771kk01i001.gif GRAPHIC 548382
  Complete submission text file 0001104659-17-050250.txt   5644646

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cldx-20170630.xml EX-101.INS 1098304
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cldx-20170630.xsd EX-101.SCH 37931
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cldx-20170630_cal.xml EX-101.CAL 56394
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cldx-20170630_lab.xml EX-101.LAB 391380
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cldx-20170630_pre.xml EX-101.PRE 262847
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cldx-20170630_def.xml EX-101.DEF 140160
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 171014745
SIC: 2835 In Vitro & In Vivo Diagnostic Substances